| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) |
|---|
| 05/06/2004 | US20040086952 Monoclonal antibody comrpising affininty for 5-lipoxygenase activating polypeptide (FLAP) for diagnosis, prevention and treatment of inflamation, asthma and glomerulonephritis; gastric cytoprotective agents |
| 05/06/2004 | US20040086942 Comprises peptide mimetic which competes for binding site of immunoglobulin receptor and prevents and treats allergic disorders |
| 05/06/2004 | US20040086905 Lipid-associated molecules |
| 05/06/2004 | US20040086904 Identifying modulators which suppress synthesis of secreted and/or membrane protein for prevention and treatment of allergic,inflammatory, skin, cardiovascular, nervous system and cancer disorders |
| 05/06/2004 | US20040086899 Compromises nuclelotide sequences coding polypeptides associated with elongation of fatty acid chains for treatment and prevention of skin, cardiovascular, inflammatory, gastrointestinal, respiratory system and bone disorders |
| 05/06/2004 | US20040086877 Multi-mode directi memory access controller and method |
| 05/06/2004 | US20040086846 Using bacterial artificial chromosomes to propagate/replicate viral nucleotide sequences; gene therapy and genetic vaccines |
| 05/06/2004 | US20040086536 Comprising an anticholinergic agent and an NO donor as the active ingredients |
| 05/06/2004 | US20040086533 For inhibiting bacterial invasion via intestinal barrier containing live Bacillus subtilis cells as an active ingredient |
| 05/06/2004 | US20040086531 Botulinum toxin oral formulation, wherein carrier is formulated to release therapeutic amounts in a gastrointestinal tract of a patient with a gastric ulcer without a significant immune system response |
| 05/06/2004 | US20040086522 Strategies to prevent autoimmune disease by vaccination with vaccines based upon Epstein-Barr virus |
| 05/06/2004 | US20040086514 Based on the finding of a specific Helicobacter pylori receptor in the human gastric epithelium; a glycolipid, lactotetraosylceramide, exclusively found in the human gastrointestinal tract |
| 05/06/2004 | US20040086505 Derived from human placenta |
| 05/06/2004 | US20040086485 Viral vector sequences in plasmid form delivered in-vivo to generate vector producing cells |
| 05/06/2004 | EP1416052A1 Process for producing 1,4-dihydroxy-2-naphthoic acid |
| 05/06/2004 | EP1415997A1 Polypeptides relating to signal transfer of advanced glycation end product receptor |
| 05/06/2004 | EP1415994A1 Retinal pigmented epithelium derived neurotrophic factor |
| 05/06/2004 | EP1415986A1 Spiro compounds |
| 05/06/2004 | EP1415773A1 Gripper |
| 05/06/2004 | EP1415667A1 Pancreatic juice secretion regulators comprising lpa receptor controller |
| 05/06/2004 | EP1415656A1 Lactobacillus strains capable of preventing diarrhoea caused by rotaviruses |
| 05/06/2004 | EP1415646A1 Gel comprising antimicrobial extract as an adjunct in the treatment of periodontitis |
| 05/06/2004 | EP1415154A2 Control of growth and repair of gastro-intestinal tissues by gastrokines and inhibitors |
| 05/06/2004 | EP1414964A2 Vegf isoform |
| 05/06/2004 | EP1414963A2 Lipid-associated molecules |
| 05/06/2004 | EP1414858A2 Single chain camelid vhh antibodies, method for their production in a mammal, and their uses |
| 05/06/2004 | EP1414853A2 Method for studying the effects of commensal microflora on mammalian intestine and treatments of gastrointestinal-associated disease based thereon |
| 05/06/2004 | EP1414849A2 Immune-modulating peptide |
| 05/06/2004 | EP1414841A1 Oligonucleotide-containing pharmacological compositions and their use |
| 05/06/2004 | EP1414825A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 05/06/2004 | EP1414812A1 Hydroxamic acid derivatives |
| 05/06/2004 | EP1414810A2 1,4-disubstituted benzo-fused cycloalkyl urea compounds |
| 05/06/2004 | EP1414808A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 05/06/2004 | EP1414806A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1414802A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 05/06/2004 | EP1414785A1 Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
| 05/06/2004 | EP1414778A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 05/06/2004 | EP1414775A2 Novel bicyclic and tricyclic cannabinoids |
| 05/06/2004 | EP1414525A2 2-(3,5-bis-trifluoromethyl-phenyl)-n-[6-(1,1-dioxo-1.lambda.6-thiomorpholin-4-yl)-4-(2-methyl or 4-fluoro-2-methyl substituted)phenyl-pyridin-3-yl]-n-methyl-isobutyramide |
| 05/06/2004 | EP1414498A2 Stabilized formulations of interferons with sulfoalkyl ether cyclodextrins |
| 05/06/2004 | EP1414495A1 Anti-microbial targeting chimeric pharmaceutical |
| 05/06/2004 | EP1414493A2 Oral immunoglobulin treatment for inflammatory bowel disease |
| 05/06/2004 | EP1414486A2 Use of glp-2 in combination with another therapeutic agent in bone-related and nutrition-related disorders |
| 05/06/2004 | EP1414471A2 Therapeutic agents comprising pro-apoptotic proteins |
| 05/06/2004 | EP1414466A1 Combinations for the treatment of inflammatory disorders |
| 05/06/2004 | EP1414455A1 Isoquinoline inhibitors of p38 |
| 05/06/2004 | EP1414452A1 Novel substituted benzimidazole dosage forms and method of using same |
| 05/06/2004 | EP1414447A1 Use of thiazole derivatives for preparing a medicine for protecting mitochondria |
| 05/06/2004 | EP1414444A1 Novel imidazolidine derivatives, their preparation and their use as vla-4 antagonists |
| 05/06/2004 | EP1414442A1 3-arylsulfonyl-7-piperazinyl- indoles, -benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
| 05/06/2004 | EP1414440A1 N-phenylpyrrole guanidine derivatives as melanocortin receptor ligands |
| 05/06/2004 | EP1414439A1 Novel pyrroles having hypolipidemic hypocholesteremic activities, process for their preparation and pharmaceutical compositions containing them and their use in medicine |
| 05/06/2004 | EP1414432A2 Methods of use for novel sulfur containing organic nitrate compounds |
| 05/06/2004 | EP1414430A2 5-aminolevulinic acid and esters, in combination with another photosensitiser, as photosensitising agents in photochemotherapy, and their uses in treating wounds |
| 05/06/2004 | EP1414428A1 Histone deacetylase enzyme-inhibiting derivatives of hydroxamic acid as new cytokine synthesis-inhibiting anti-inflammatory drugs |
| 05/06/2004 | EP1414426A1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 05/06/2004 | EP1414415A2 Nutritional supplements and methods of using same |
| 05/06/2004 | EP1414316A1 Nutritional composition preventing bacterial overgrowth |
| 05/06/2004 | EP1268407B1 Propenecarboxylic acid amidoxime derivatives, a process for the preparation thereof, and pharmaceutical compositions containing the same |
| 05/06/2004 | EP1261613B1 Gastro-specific prodrugs |
| 05/06/2004 | EP1257548B1 Benzofuran carboxamides and their therapeutic use |
| 05/06/2004 | EP1222162B1 Novel ltb4-antagonist, method for the production thereof and its use as a medicament |
| 05/06/2004 | EP1163237B1 Amide derivatives |
| 05/06/2004 | EP1123283B1 Thiazole-derivatives |
| 05/06/2004 | EP1060181B1 Substituted pyrrolobenzimidazoles for treating inflammatory diseases |
| 05/06/2004 | EP1047395B1 Mixture containing honey, at least one essential oil and/or at least one essential oil derivative |
| 05/06/2004 | EP0868197B1 Anti-l-selectin antibodies for prevention of multiple organ failure and acute organ damage |
| 05/06/2004 | EP0729297A4 Hepatoblasts and method of isolating same |
| 05/06/2004 | CA2503088A1 Therapeutic and/or preventive agent for dyschezia |
| 05/06/2004 | CA2502453A1 Angiogenesis inducer |
| 05/06/2004 | CA2500836A1 Metal-containing materials, compositions and methods |
| 05/05/2004 | CN1494543A Substituted benzofuran-2-carboxamides derivatives |
| 05/05/2004 | CN1494541A Heterocyclic inhibitors of ERK 2 and uses thereof |
| 05/05/2004 | CN1494539A Antagonists of MCP-1 function and methods of use thereof |
| 05/05/2004 | CN1494426A Bacterial translocation inhibitor and method of inhibiting bacterial translocation |
| 05/05/2004 | CN1494424A IL-8 receptor antagonists |
| 05/05/2004 | CN1494374A Preparation of compositions comprising bacterial strains and volatile plant extracts and therapeutic and industrial applications thereof |
| 05/05/2004 | CN1493678A Health care and nourish life wine and its making method |
| 05/05/2004 | CN1493676A Enrich yin invigorate yang dispel disease medicated wine |
| 05/05/2004 | CN1493580A Ibuprofen ribavirin ester and preparation method and use thereof |
| 05/05/2004 | CN1493578A Preparation method of golden peach glycoside and its new use in medicine |
| 05/05/2004 | CN1493568A Roxatiding bismuth citrate and its preparation method and use |
| 05/05/2004 | CN1493359A Chinese caterpillar fungus glossy ganoderma health protection food and its production method |
| 05/05/2004 | CN1493356A Medicine for treating gastrointestinal tract disease |
| 05/05/2004 | CN1493355A Medicine for treating gastrointestinal tract diseases |
| 05/05/2004 | CN1493352A Chinese compound medicine for treating gastrodynia and its prepartion method |
| 05/05/2004 | CN1493343A Ginseng and aconite spraying agent for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493342A Ginseng and aconite injection liquid for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493341A Ginseng and aconite capsule for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493340A Ginseng and aconite preparation for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493339A Ginseng and aconite oral liquid for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493338A Ginseng and aconite powder for injection for treating qi vacuity and yang desertion ard its preparation method |
| 05/05/2004 | CN1493337A Ginseng and aconite freeze dried powder for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493336A Ginseng and aconite granules for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493335A Ginseng and aconite tablet for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493334A Ginseng and aconite tablet for injection use for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493333A Ginseng and aconite high concentration injection liquid for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493332A Ginseng and aconite transfusion for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493331A Ginseng and aconite quick release pill for treating qi vacuity and yang desertion and its preparation method |
| 05/05/2004 | CN1493330A Ginseng and aconite preparation for treating qi vacuity yang desertion and its extraction method |